Top Markets
#1 ADO Protocol ADO Protocol +194.54%
#2 Islamic Coin Islamic Coin +155.33%
#3 GoPlus Security GoPlus Security +40.11%
#4 GAIB AID GAIB AID +24.67%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.36%
#6 Wrapped NXM Wrapped NXM +14.17%
#7 Verus Coin Verus Coin +13.65%
#8 Casper Network Casper Network +13.15%
#9 Pons Pons +12.20%
#10 o1.exchange o1.exchange +12.20%
Coin of the day
ADO Protocol ADO Protocol
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Anew Medical, Inc. Anew Medical, Inc.

Anew Medical, Inc.

WENA
Rangering i aksjer #33462
Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing... Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing innovative treatments for conditions affecting the brain and nervous system, age-related illnesses, and specialized diagnostic tools. Their pipeline includes advanced cell and gene therapies specifically designed to alleviate symptoms of aging-related conditions, such as dementia, Alzheimer's disease, and various neuromuscular disorders. Additionally, Anew Medical is engaged in developing biologics and biosimilars for cancer treatment, alongside research into therapies targeting melanocortin receptors. A key strategic alliance exists with Japan's Okinawa Research Center, focusing on the collaborative research and development of Klotho gene therapy. This initiative aims to extend human longevity and diminish the impact of age-related diseases. The company maintains its headquarters in Omaha, Nebraska.
Aksjekurs
$0.5099
Sist synkronisert: 2024-10-15
Markedsverdi
$7.60M
Endring (1 dag)
2.02%
Endring (1 år)
0.00%
Land
US
Handel Anew Medical, Inc. (WENA)

Kategori

Healthcare
Inntekter for Anew Medical, Inc. (WENA)
Inntekter i Jun 2024 TTM: $114.12K
Ifølge Anew Medical, Inc. sine nyeste økonomiske rapporter er selskapets nåværende resultat $114.12K. I 2022 hadde selskapet et resultat på $1.56M, en økning sammenlignet med resultatet i 2021, som var $-1.11M. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Anew Medical, Inc. fra 2021 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
2026 (TTM) $114.12K -94.40%
2023 $2.04M 30.95%
2022 $1.56M -240.25%
2021 $-1.11M 0.00%
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B 4,622,261.26%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B 1,709,242.25%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B 2,633,790.84%
BE